Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals is focused on advancing novel product candidates to improve or restore cellular energy production, with a mission to translate knowledge of cellular metabolism into medicines that improve patients' lives. The company is engaged in clinical trials and research in cardiometabolic disorders.
Industries
Nr. of Employees
small (1-50)
Imbria Pharmaceuticals, Inc.
Patents
Methods of treating rheumatic diseases using trimetazidine-based compounds
US-12318382-B2
View DetailsMethods of treating kidney conditions using modified forms of trimetazidine
US-12285428-B2
View DetailsMethods of treating non-obstructive hypertrophic cardiomyopathy using modified forms of trimetazidine
US-12233058-B2
View DetailsMethods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl] piperazin-1-yl]ethyl pyridine-3-carboxylate
US-12110275-B2
View DetailsMethods of treating heart failure with hibernating myocardium using modified forms of trimetazidine
US-12076318-B2
View Details
Methods of treating rheumatic diseases using trimetazidine-based compounds
US-12318382-B2
View DetailsMethods of treating kidney conditions using modified forms of trimetazidine
US-12285428-B2
View DetailsMethods of treating non-obstructive hypertrophic cardiomyopathy using modified forms of trimetazidine
US-12233058-B2
View DetailsMethods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl] piperazin-1-yl]ethyl pyridine-3-carboxylate
US-12110275-B2
View DetailsMethods of treating heart failure with hibernating myocardium using modified forms of trimetazidine
US-12076318-B2
View DetailsProducts
Clinical-stage therapeutic candidate targeting cellular energy production
An investigational therapeutic designed to enhance or restore cellular energy production, under clinical evaluation for cardiometabolic disorders including heart failure subtypes; results from clinical studies have been published and presented.
Clinical-stage therapeutic candidate targeting cellular energy production
An investigational therapeutic designed to enhance or restore cellular energy production, under clinical evaluation for cardiometabolic disorders including heart failure subtypes; results from clinical studies have been published and presented.
Services
Design and conduct of sponsor-led clinical trials, data collection and analysis, and dissemination of results through publications and conference presentations.
Provision of educational materials describing investigational therapeutics, clinical programs, and implications for patients and healthcare providers.
Design and conduct of sponsor-led clinical trials, data collection and analysis, and dissemination of results through publications and conference presentations.
Provision of educational materials describing investigational therapeutics, clinical programs, and implications for patients and healthcare providers.
Expertise Areas
- Cardiometabolic drug development
- Clinical trial management and execution
- Translational research in cellular metabolism
- Clinical data publication and scientific communications
Key Technologies
- Cellular energy metabolism modulation
- Clinical trial platforms for Phase II studies
- Clinical data analysis and peer-reviewed dissemination
- Cardiometabolic therapeutic development